1-11 of 11
B Peterson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sustained remissions in CLL after frontline FCR treatment with very-long-term follow-up

Clinical Trials & Observations Brief Report
Philip A. Thompson, Alexandre Bazinet, William G. Wierda, Constantine S. Tam, Susan M. O’Brien, Satabdi Saha, Christine B. Peterson, William Plunkett, Michael J. Keating
Journal: Blood
Blood (2023) 142 (21): 1784–1788.
https://doi.org/10.1182/blood.2023020158
Published: 2023
Includes: Supplemental data
Journal Articles

Outcomes of Breakthrough COVID-19 Infections in Patients with Hematologic Malignancies

Kelly S. Chien, Christine B. Peterson, Elliana Young, Dai Chihara, Elisabet E. Manasanch, Jeremy L. Ramdial, Philip A. Thompson
Journal: Blood
Blood (2022) 140 (Supplement 1): 10938–10939.
https://doi.org/10.1182/blood-2022-169993
Published: 2022
Journal Articles

Venetoclax Consolidation Achieves Durable Off-Treatment Remissions in Patients with High Risk CLL Who Have Been on Ibrutinib More Than a Year

Philip A. Thompson, Michael J. Keating, Alessandra Ferrajoli, Nitin Jain, Christine B. Peterson, Naveen Garg, Ana Ayala, Jon A Hernandez, Tapan M. Kadia, Prithviraj Bose, Naveen Pemmaraju, Nicholas Short, William G. Wierda
Journal: Blood
Blood (2022) 140 (Supplement 1): 238–240.
https://doi.org/10.1182/blood-2022-170030
Published: 2022
Journal Articles

Flow Cytometric Analysis of Microbial Diversity in Patients with Aggressive Lymphoma Disease Undergoing Chemoimmunotherapy

Maren Schmiester, René Maier, René Riedel, Marco Frentsch, Robert R. Jenq, Christine B. Peterson, Liangliang Zhang, Lars Bullinger, Hyun-Dong Chang, Il-Kang Na
Journal: Blood
Blood (2021) 138 (Supplement 1): 4005.
https://doi.org/10.1182/blood-2021-146429
Published: 2021
Journal Articles

Venetoclax Consolidation in Patients with High-Risk CLL Who Have Been on Ibrutinib More Than a Year Achieves a High Rate of Undetectable Minimal Residual Disease

Philip A. Thompson, Yan Wang, Michael J. Keating, Alessandra Ferrajoli, Nitin Jain, Christine B. Peterson, Naveen Garg, Chongjuan Wei, Ana Ayala, Tapan M. Kadia, Prithviraj Bose, Naveen Pemmaraju, Nicholas J. Short, William G. Wierda
Journal: Blood
Blood (2021) 138 (Supplement 1): 3723.
https://doi.org/10.1182/blood-2021-149919
Published: 2021
Journal Articles

The Addition of Venetoclax to Ibrutinib Achieves a High Rate of Undetectable Minimal Residual Disease in Patients with High-Risk CLL

Philip A. Thompson, MB, MS, Alessandra Ferrajoli, MD, Nitin Jain, MD, Yan Wang, Christine B Peterson, Naveen Garg, MD, Chongjuan Wei, PhD, Ana Ayala, RN, Tapan M. Kadia, MD, Prithviraj Bose, MD, Naveen Pemmaraju, MD, Nicholas J. Short, MD, Michael J. Keating, MBBS, William G. Wierda, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-141716
Published: 2020
Journal Articles

AML Cells Alter Bone Homeostasis By Promoting the Formation of Immature Bone and Resorption of Mature Bone That Supports Leukemia Progression

Anudishi Tyagi, PhD, Bin Yuan, Stanley Ly, Fouad El-Dana, MD, Vinitha Mary Kuruvilla, MSc, Qi Zhang, PhD, Christine B Peterson, Xin Zhou, PhD, Benoit deCrombrugghe, Michael Andreeff, MD PhD, Marina Konopleva, MD PhD, Behrang Amini, MD PhD, Venkata Lokesh Battula, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27.
https://doi.org/10.1182/blood-2020-142777
Published: 2020
Journal Articles

Hypertension, Cardiovascular and Renal Complications Observed in Patients with Chronic Lymphocytic Leukemia Receiving Long-Term Therapy with Ibrutinib

Jade Jones, MD, Binsah Susan George, MD, Christine B Peterson, Thao-Mi Tran Ha, Jan A. Burger, MD PhD, Nitin Jain, MD, Michael J. Keating, MBBS, William G. Wierda, MD PhD, Jean-Bernard Durand, MD, Alessandra Ferrajoli, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-141284
Published: 2020
Journal Articles

Chronic Lymphocytic Leukemia with Deletion 13q: Prognostic Predictors and Outcome after Treatment with Fludarabine, Cyclophosphamide and Rituximab (FCR)

Abdul Rashid Shah, MD, Tariq Muzzafar, MBBS, Romana Asad, MD, Christine B Peterson, Hagop M. Kantarjian, MD, Alessandra Ferrajoli, MD, William G Wierda, MD PhD, Jan A. Burger, MD PhD, Nitin Jain, MD, Gautam Borthakur, MD, Maliha Khan, MD, Abhishek Chilkulwar, MD, Brion Randolph, MD, Lohith Gowda, MD, Michael J Keating
Journal: Blood
Blood (2017) 130 (Supplement 1): 5337.
https://doi.org/10.1182/blood.V130.Suppl_1.5337.5337
Published: 2017
Journal Articles

Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: a Cancer and Leukemia Group B study

RA Newman, B Peterson, FR Davey, C Brabyn, H Collins, VL Brunetto, DB Duggan, RB Weiss, I Royston, FE Millard
Journal: Blood
Blood (1993) 82 (4): 1239–1246.
https://doi.org/10.1182/blood.V82.4.1239.1239
Published: 1993
Journal Articles

Four new recurring translocations in non-Hodgkin lymphoma

EG Levine, DC Arthur, J Machnicki, G Frizzera, D Hurd, B Peterson, KJ Gajl- Peczalska, CD Bloomfield
Journal: Blood
Blood (1989) 74 (5): 1796–1800.
https://doi.org/10.1182/blood.V74.5.1796.1796
Published: 1989